Variant report
Variant | nsv583314 |
---|---|
Chromosome Location | chr2:151035328-151038142 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140844500 | chr2:151035456-151035457 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575241779 | chr2:151035505-151035506 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566809332 | chr2:151035527-151035528 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs76459111 | chr2:151035547-151035548 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs149714805 | chr2:151035631-151035632 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs577185780 | chr2:151035662-151035663 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs543165640 | chr2:151035684-151035685 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145666444 | chr2:151035693-151035694 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs573791344 | chr2:151035711-151035712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542787416 | chr2:151035742-151035743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186523217 | chr2:151035778-151035779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374909732 | chr2:151035809-151035810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs528413561 | chr2:151035813-151035814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568544411 | chr2:151035833-151035834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533693627 | chr2:151035834-151035835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535679303 | chr2:151035837-151035838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545296413 | chr2:151035841-151035842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565283587 | chr2:151035884-151035885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs28407206 | chr2:151035905-151035906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs545887993 | chr2:151035936-151035937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs550836392 | chr2:151035953-151035954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181156979 | chr2:151035955-151035956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530258564 | chr2:151035970-151035971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547154417 | chr2:151035989-151035990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs367627487 | chr2:151036004-151036005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566689073 | chr2:151036016-151036017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs538966545 | chr2:151036021-151036022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186178902 | chr2:151036056-151036057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189665814 | chr2:151036065-151036066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs113548635 | chr2:151036069-151036070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs376079794 | chr2:151036091-151036092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556810435 | chr2:151036094-151036095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573667754 | chr2:151036118-151036119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs199906709 | chr2:151036132-151036133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542325299 | chr2:151036136-151036137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs368672176 | chr2:151036146-151036147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs371998506 | chr2:151036147-151036148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs145517344 | chr2:151036153-151036154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs545331688 | chr2:151036161-151036162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565168105 | chr2:151036183-151036184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs530856501 | chr2:151036201-151036202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376323972 | chr2:151036206-151036207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561259209 | chr2:151036216-151036217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530226290 | chr2:151036261-151036262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs546747185 | chr2:151036288-151036289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs137892232 | chr2:151036298-151036299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532525314 | chr2:151036337-151036338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs371550179 | chr2:151036368-151036369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552489136 | chr2:151036409-151036410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs569189325 | chr2:151036418-151036419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Glioblastoma | 21080181 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 19156171 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Autism | 20808228 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:151032200-151035400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
2 | chr2:151033200-151035600 | Weak transcription | Fetal Intestine Small | intestine |
3 | chr2:151034800-151035800 | Enhancers | Liver | Liver |
4 | chr2:151034800-151035800 | Enhancers | Fetal Intestine Large | intestine |
5 | chr2:151034800-151035800 | Enhancers | Hela-S3 | cervix |
6 | chr2:151035000-151035400 | Enhancers | Rectal Mucosa Donor 29 | rectum |
7 | chr2:151035000-151035600 | Weak transcription | A549 | lung |
8 | chr2:151035200-151035400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr2:151035200-151035600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr2:151035200-151035600 | Enhancers | K562 | blood |
11 | chr2:151035200-151035800 | Enhancers | Fetal Lung | lung |
12 | chr2:151035400-151035600 | Enhancers | Fetal Kidney | kidney |
13 | chr2:151035400-151035800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
14 | chr2:151035400-151047000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
15 | chr2:151035600-151035800 | Enhancers | Fetal Intestine Small | intestine |
16 | chr2:151035600-151035800 | Enhancers | A549 | lung |
17 | chr2:151035800-151038800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
18 | chr2:151035800-151039200 | Weak transcription | Fetal Lung | lung |